Translational Innovation with Industry: From Mechanism to Medicine

8 October 2026 | 10:45 – 12:00

This session will highlight how translational innovation in partnership with industry can bridge the gap between mechanistic understanding and the development of new medicines. Speakers will showcase how physiologically relevant systems can improve disease modelling, strengthen predictive value, and accelerate therapeutic development.

Chair: Geurt Stokman (TNO)

Speakers: Mathijs de Kleer (NewAmsterdam Pharma), Emily Rayner (TNO), Achi Haider (Roche), Sjef de Kimpe (ProQR Therapeutics)

Time Schedule

10:45-10:50Introduction
10:50-11:05Mattijs de Kleer, NewAmsterdam Pharma - Elucidating the mechanism of action of the CETP inhibitor obicetrapib through strategic partnerships
11:05-11:20Sjef de Kimpe, ProQR Therapeutics - Humanized mouse liver models for Preclinical evaluation of RNA editing oligonucleotides 
11:20-11:35
Emily Rayner, TNO - A Human Ex Vivo Vaginal Barrier Model for Advancing Women’s Health Research
11:35-11:50 Achi Haider, Roche - Radioligand Applications in Translational Drug Development
11:50-12:00Q&A

Contact           

Connect                   

Hyphen Projects 
Veerstraat 37
1211 HJ Hilversum

Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01		         
 
 

                                    

Register now
Terms & Conditions 
Privacy Policy

© Copyright 2023 by Hyphen Projects | All rights reserved